Pharvaris NV (PHVS)
18.76
+0.66
(+3.65%)
USD |
NASDAQ |
Jun 14, 16:00
18.59
-0.17
(-0.91%)
After-Hours: 20:00
Pharvaris Enterprise Value: 611.83M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 611.83M |
| June 13, 2024 | 576.31M |
| June 12, 2024 | 581.69M |
| June 11, 2024 | 456.84M |
| June 10, 2024 | 463.29M |
| June 07, 2024 | 445.54M |
| June 06, 2024 | 506.89M |
| June 05, 2024 | 490.20M |
| June 04, 2024 | 504.73M |
| June 03, 2024 | 555.32M |
| May 31, 2024 | 622.59M |
| May 30, 2024 | 619.36M |
| May 29, 2024 | 646.27M |
| May 28, 2024 | 659.73M |
| May 24, 2024 | 688.25M |
| May 23, 2024 | 654.34M |
| May 22, 2024 | 676.95M |
| May 21, 2024 | 709.78M |
| May 20, 2024 | 714.08M |
| May 17, 2024 | 697.40M |
| May 16, 2024 | 770.59M |
| May 15, 2024 | 791.58M |
| May 14, 2024 | 721.61M |
| May 13, 2024 | 741.53M |
| May 10, 2024 | 757.13M |
| Date | Value |
|---|---|
| May 09, 2024 | 709.24M |
| May 08, 2024 | 724.31M |
| May 07, 2024 | 819.56M |
| May 06, 2024 | 822.79M |
| May 03, 2024 | 818.48M |
| May 02, 2024 | 868.53M |
| May 01, 2024 | 924.50M |
| April 30, 2024 | 925.58M |
| April 29, 2024 | 864.23M |
| April 26, 2024 | 858.85M |
| April 25, 2024 | 827.63M |
| April 24, 2024 | 745.83M |
| April 23, 2024 | 747.98M |
| April 22, 2024 | 725.38M |
| April 19, 2024 | 633.36M |
| April 18, 2024 | 593.53M |
| April 17, 2024 | 743.14M |
| April 16, 2024 | 732.38M |
| April 15, 2024 | 686.63M |
| April 12, 2024 | 780.81M |
| April 11, 2024 | 802.88M |
| April 10, 2024 | 800.73M |
| April 09, 2024 | 847.55M |
| April 08, 2024 | 826.02M |
| April 05, 2024 | 816.33M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-127.45M
Minimum
Dec 02 2022
1.294B
Maximum
Dec 29 2023
430.62M
Average
367.47M
Median
Sep 07 2021
Enterprise Value Benchmarks
| uniQure NV | -216.16M |
| ProQR Therapeutics NV | 37.52M |
| Merus NV | 3.472B |
| argenx SE | 19.82B |
| Pharming Group | 512.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.43M |
| Total Expenses (Quarterly) | 30.75M |
| EPS Diluted (Quarterly) | -0.5655 |
| Earnings Yield | -10.64% |